Correlation Between Amgen and UroGen Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and UroGen Pharma, you can compare the effects of market volatilities on Amgen and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and UroGen Pharma.

Diversification Opportunities for Amgen and UroGen Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Amgen and UroGen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of Amgen i.e., Amgen and UroGen Pharma go up and down completely randomly.

Pair Corralation between Amgen and UroGen Pharma

Given the investment horizon of 90 days Amgen Inc is expected to generate 0.52 times more return on investment than UroGen Pharma. However, Amgen Inc is 1.93 times less risky than UroGen Pharma. It trades about 0.2 of its potential returns per unit of risk. UroGen Pharma is currently generating about 0.06 per unit of risk. If you would invest  25,722  in Amgen Inc on December 28, 2024 and sell it today you would earn a total of  4,855  from holding Amgen Inc or generate 18.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  UroGen Pharma

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Amgen displayed solid returns over the last few months and may actually be approaching a breakup point.
UroGen Pharma 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in UroGen Pharma are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, UroGen Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Amgen and UroGen Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and UroGen Pharma

The main advantage of trading using opposite Amgen and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.
The idea behind Amgen Inc and UroGen Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals